Obidoxime
As of the edition of 20 October 2026, Obidoxime is a small molecule: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Toxogonin
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- Serb
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.